Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Isabelle Ader

Showing results (1-10 of 32) with videos related to

Pageof 4
Sort By:
Anti-Cancer Agents in Medicinal Chemistry|June 29, 2011
Hypoxia-inducible factors and sphingosine 1-phosphate signalingOlivier Cuvillier, Isabelle Ader
Molecular Cancer Therapeutics|August 11, 2016
FTY720 (Fingolimod) Inhibits HIF1 and HIF2 Signaling, Promotes Vascular Remodeling, and Chemosensitizes in Renal Cell Carcinoma Animal ModelCécile Gstalder, Isabelle Ader, Olivier Cuvillier
Cancer Research|April 23, 2009
When the sphingosine kinase 1/sphingosine 1-phosphate pathway meets hypoxia signaling: new targets for cancer therapyIsabelle Ader, Bernard Malavaud, Olivier Cuvillier
Cancer Research|October 17, 2008
Sphingosine kinase 1: a new modulator of hypoxia inducible factor 1alpha during hypoxia in human cancer cellsIsabelle Ader, Leyre Brizuela, Pierre Bouquerel, et al.
Molecular Cancer Therapeutics|July 13, 2012
First evidence of sphingosine 1-phosphate lyase protein expression and activity downregulation in human neoplasm: implication for resistance to therapeutics in prostate cancerLeyre Brizuela, Isabelle Ader, Catherine Mazerolles, et al.
Advances in Cancer Research|January 8, 2013
Hypoxia, therapeutic resistance, and sphingosine 1-phosphateOlivier Cuvillier, Isabelle Ader, Pierre Bouquerel, et al.
European Journal of Medicinal Chemistry|August 1, 2014
Synthesis, structures, and selective toxicity to cancer cells of gold(I) complexes involving N-heterocyclic carbene ligandsLuca Boselli, Isabelle Ader, Maëlle Carraz, et al.
Current Molecular Pharmacology|March 23, 2010
Activation of sphingosine kinase-1 in cancer: implications for therapeutic targetingOlivier Cuvillier, Isabelle Ader, Pierre Bouquerel, et al.
Oncogene|September 13, 2002
The radioprotective effect of the 24 kDa FGF-2 isoform in HeLa cells is related to an increased expression and activity of the DNA dependent protein kinase (DNA-PK) catalytic subunitIsabelle Ader, Catherine Muller, Jacques Bonnet, et al.
Frontiers in Physiology|July 19, 2021
Lactate Fluxes and Plasticity of Adipose Tissues: A Redox PerspectiveDamien Lagarde, Yannick Jeanson, Jean-Charles Portais, et al.
Pageof 4

Showing results (1-10 of 32) with videos related to

Sort By:
Pageof 4
Anti-Cancer Agents in Medicinal Chemistry|June 29, 2011
Hypoxia-inducible factors and sphingosine 1-phosphate signalingOlivier Cuvillier, Isabelle Ader
Molecular Cancer Therapeutics|August 11, 2016
FTY720 (Fingolimod) Inhibits HIF1 and HIF2 Signaling, Promotes Vascular Remodeling, and Chemosensitizes in Renal Cell Carcinoma Animal ModelCécile Gstalder, Isabelle Ader, Olivier Cuvillier
Cancer Research|April 23, 2009
When the sphingosine kinase 1/sphingosine 1-phosphate pathway meets hypoxia signaling: new targets for cancer therapyIsabelle Ader, Bernard Malavaud, Olivier Cuvillier
Cancer Research|October 17, 2008
Sphingosine kinase 1: a new modulator of hypoxia inducible factor 1alpha during hypoxia in human cancer cellsIsabelle Ader, Leyre Brizuela, Pierre Bouquerel, et al.
Molecular Cancer Therapeutics|July 13, 2012
First evidence of sphingosine 1-phosphate lyase protein expression and activity downregulation in human neoplasm: implication for resistance to therapeutics in prostate cancerLeyre Brizuela, Isabelle Ader, Catherine Mazerolles, et al.
Advances in Cancer Research|January 8, 2013
Hypoxia, therapeutic resistance, and sphingosine 1-phosphateOlivier Cuvillier, Isabelle Ader, Pierre Bouquerel, et al.
European Journal of Medicinal Chemistry|August 1, 2014
Synthesis, structures, and selective toxicity to cancer cells of gold(I) complexes involving N-heterocyclic carbene ligandsLuca Boselli, Isabelle Ader, Maëlle Carraz, et al.
Current Molecular Pharmacology|March 23, 2010
Activation of sphingosine kinase-1 in cancer: implications for therapeutic targetingOlivier Cuvillier, Isabelle Ader, Pierre Bouquerel, et al.
Oncogene|September 13, 2002
The radioprotective effect of the 24 kDa FGF-2 isoform in HeLa cells is related to an increased expression and activity of the DNA dependent protein kinase (DNA-PK) catalytic subunitIsabelle Ader, Catherine Muller, Jacques Bonnet, et al.
Frontiers in Physiology|July 19, 2021
Lactate Fluxes and Plasticity of Adipose Tissues: A Redox PerspectiveDamien Lagarde, Yannick Jeanson, Jean-Charles Portais, et al.
Pageof 4